GlassScriptPhysician profile
James Watlington
NPI 1801359047
$1,191.32
in general payments reported to CMS, 2019-2025
10 companies · $23.12 in 2025
The $23.12 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.55 · 2022: $353 · 2023: $190 · 2024: $610 · 2025: $23.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676 · Travel and Lodging: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.60 |
| Travel and Lodging | $147.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $344.10 | 2022-2024 | Phasix Mesh |
| Stryker Corporation | $243.00 | 2023-2024 | Spy-Phi System, 1788 |
| Medical Device Business Services, INC. | $215.31 | 2024 | |
| Ethicon US, LLC | $118.49 | 2024-2025 | Stratafix, Surgiflo Hemostatic Matrix, Dermabond |
| La Jolla Pharmaceutical Company | $94.72 | 2022 | |
| Depuy Synthes Sales INC. | $78.75 | 2024 | Matrixrib |
| Kci USA, INC. | $42.52 | 2022 | |
| Medtronic, INC. | $24.24 | 2022 | |
| Mozarc Medical US LLC | $15.64 | 2023 | Chameleon |
| E.R. Squibb & Sons, L.L.C. | $14.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Watlington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.